This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Digmbio. Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Younghoon Kim: Innovator in Pharmaceutical Composition
Introduction
Younghoon Kim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases.
Latest Patents
Younghoon Kim holds a patent for isoquinolinone derivatives, which includes a method for preparing these compounds and a pharmaceutical composition aimed at preventing or treating poly(ADP-ribose) polymerase-1 (PARP-1)-related diseases. The invention highlights the isoquinolinone derivatives' exceptional PARP-1 inhibitory effect at nanomolar concentrations. Additionally, these derivatives demonstrate a strong cytoprotective effect, particularly in treating ophthalmic diseases, including retinal disorders.
Career Highlights
Throughout his career, Younghoon Kim has worked with prominent companies such as Digmbio, Inc. and Samsung SDI Co., Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Younghoon Kim has collaborated with notable colleagues, including Eunhee Kim and Changmin Park. Their joint efforts have further advanced research in the field of pharmaceuticals.
Conclusion
Younghoon Kim's innovative work in developing isoquinolinone derivatives showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of PARP-1-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile